Non-Infectious Macular Edema Treatment Market Is Projected To Expand At 6.9% CAGR To US$ 29 ...
The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the <a target=_blank href= ...
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and ...
BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to ...
PharmiWeb12 小时
OKYO Pharma Announces Chairman and CEO Acquire Shares
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...